PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain

✍ Scribed by A. Sicras-Mainar; J. Rejas; R. Navarro-Artieda; A. Aguado-Jodar; A. Ruiz-Torrejón; M.G. Kvasz

• Book ID: 119312287
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 61 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.1442